β-elemene decreases cell invasion by upregulating E-cadherin expression in MCF-7 human breast cancer cells

Oncology Reports

Volumn 30, Issue 2, 2013, Pages 745-750

  Zhang, Xian ^a   Zhang, Yang ^a   Li, Yinghua ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

elemene; Breast cancer; Cell invasion; E cadherin; MCF 7

Indexed keywords

BETA ELEMENE; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; METASTASIS ASSOCIATED PROTEIN 3; REGULATOR PROTEIN; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MEDICINE, CHINESE TRADITIONAL; NEOPLASM PROTEINS; RNA, MESSENGER; SESQUITERPENES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84879683793     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2519     Document Type: Article

References (33)

1. Hazan RB and Norton L: The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J Biol Chem 273: 9078-9084, 1998. (Pubitemid 28176196)
2. Cheng CW, Wu PE, Yu JC, et al: Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 20: 3814-3823, 2001.
3. Berx G, Cleton-Jansen AM, Nollet F, et al: E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14: 6107-6115, 1995. (Pubitemid 26007298)
4. Vos CB, Cleton-Jansen AM, Berx G, et al: E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76: 1131-1133, 1997. (Pubitemid 27448007)
5. Yoshida R, Kimura N, Harada Y and Ohuchi N: The loss of E-cadherin, α- and β-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Int J Oncol 18: 513-520, 2001.
6. Parker C, Rampaul RS, Pinder SE, et al: E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer 85: 1958-1963, 2001. (Pubitemid 34775335)
7. Kowalski PJ, Rubin MA and Kleer CG: E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5: R217-R222, 2003.
8. Lu JJ, Dang YY, Huang M, et al: Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae - a review. J Ethnopharmacol 143: 406-411, 2012.
9. Wang G, Li X, Huang F, et al: Antitumor effect of β-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 62: 881-893, 2005. (Pubitemid 40655635)
10. Yao YQ, Ding X, Jia YC, et al: Anti-tumor effect of β-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett 264: 127-134, 2008. (Pubitemid 351602131)
11. Liu J, Zhang Y, Qu J, et al: β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer 11: 183, 2011.
12. Li X, Wang G, Zhao J, et al: Antiproliferative effect of β-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci 62: 894-904, 2005. (Pubitemid 40655636)
13. Chen W, Lu Y, Wu J, et al: Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis. Cancer Chemother Pharmacol 67: 799-808, 2011.
14. Yu Z, Wang R, Xu L, et al: β-Elemene piperazine derivatives induce apoptosis in human leukemia cells through downregulation of c-FLIP and generation of ROS. PLoS One 6: e15843, 2011.
15. Zhang B, Zhang X, Tang B, et al: Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression. Breast Cancer Res Treat 136: 399-406, 2012.
16. Oesterreich S, Deng W, Jiang S, et al: Estrogen-mediated down-regulation of E-cadherin in breast cancer cells. Cancer Res 63: 5203-5208, 2003. (Pubitemid 37139828)
17. Scherbakov AM, Andreeva OE, Shatskaya VA and Krasil'nikov MA: The relationships between snail1 and estrogen receptor signaling in breast cancer cells. J Cell Biochem 113: 2147-2155, 2012.
18. van Horssen R, Hollestelle A, Rens JA, et al: E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells. Breast Cancer Res Treat 136: 365-377, 2012.
19. Foroni C, Broggini M, Generali D and Damia G: Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev 38: 689-697, 2012.
20. Korpal M, Lee ES, Hu G and Kang Y: The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914, 2008.
21. Nam JS, Ino Y, Kanai Y, et al: 5-aza-2'-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis. Clin Exp Metastasis 21: 49-56, 2004. (Pubitemid 38365657)
22. Peng G, Wargovich MJ and Dixon DA: Anti-proliferative effects of green tea polyphenol EGCG on Ha-Ras-induced transformation of intestinal epithelial cells. Cancer Lett 238: 260-270, 2006. (Pubitemid 43867912)
23. Lu Z, Ghosh S, Wang Z and Hunter T: Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4: 499-515, 2003. (Pubitemid 38050046)
24. Mauro L, Pellegrino M, Lappano R, et al: E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor. Breast Cancer Res Treat 121: 79-89, 2010.
25. Belguise K, Guo S and Sonenshein GE: Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor α expression reversing invasive phenotype of breast cancer cells. Cancer Res 67: 5763-5770, 2007. (Pubitemid 46985009)
26. Helguero LA, Lindberg K, Gardmo C, et al: Different roles of estrogen receptors α and β in the regulation of E-cadherin protein levels in a mouse mammary epithelial cell line. Cancer Res 68: 8695-8704, 2008.
27. Planas-Silva MD and Waltz PK: Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 104: 11-21, 2007. (Pubitemid 46412987)
28. Cardamone MD, Bardella C, Gutierrez A, et al: ERα as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells. Proc Natl Acad Sci USA 106: 7420-7425, 2009.
29. Kumar R: Another tie that binds the MTA family to breast cancer. Cell 113: 142-143, 2003.
30. Fujita N, Kajita M, Taysavang P and Wade PA: Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells. Mol Endocrinol 18: 2937-2949, 2004. (Pubitemid 39577917)
31. Mishra SK, Talukder AH, Gururaj AE, et al: Upstream determinants of estrogen receptor-α regulation of metastatic tumor antigen 3 pathway. J Biol Chem 279: 32709-32715, 2004. (Pubitemid 39014730)
32. Yu JC, Hsu HM, Chen ST, et al: Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility. J Biomed Sci 13: 419-432, 2006.
33. Toh Y and Nicolson GL: The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis 26: 215-227, 2009.